Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
- gabapentin-100mg 1000s - gabapentin 100mg 1000s
- gabapentin-100mg 100s - gabapentin 100mg 100s
- gabapentin-100mg 500s - gabapentin 100mg 500s
- gabapentin-300mg 1000s - gabapentin 300mg 1000s
- gabapentin-300mg 100s - gabapentin 300mg 100s
- gabapentin-300mg 500s - gabapentin 300mg 500s
- gabapentin-400mg 100s - gabapentin 400mg 100s
- gabapentin-400mg 500s - gabapentin 400mg 500s
- gabapentin-600mg 100s - gabapentin 600mg 100s
- gabapentin-600mg 500s - gabapentin 600mg 500s
- gabapentin-800mg 100s - gabapentin 800mg 100s
- gabapentin-800mg 500s - gabapentin 800mg 500s
- Figure 1 - image 01
- Figure 2 - image 02
- Figure 3 - image 03
- image-04 - image 04
- Gabapentin Structural Formula - image 05
- image-09 - image 09
Product Label Images
The following 18 images provide visual information about the product associated with Gabapentin NDC 82619-142 by Creekwood Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
gabapentin-100mg 100s - gabapentin 100mg 100s

This text seems to be a label from a medication container for Gabapentin capsules, including information on dosage and the pharmacist's guidance. It indicates details such as the name of the medication, quantity (100 capsules), and NDC code (82619-142.01). The label also notes that this medication is for prescription-only use (Rx Only).*
gabapentin-400mg 100s - gabapentin 400mg 100s

Description: Gabapentin capsules in a pack of 100 with the brand name Creekwood. This prescription medication is used for treating certain conditions as directed by a healthcare provider. The National Drug Code (NDC) for this product is 82619-144-01. Please note that this medication is for prescription use only.*
gabapentin-600mg 100s - gabapentin 600mg 100s

This text appears to be a label or information regarding a medication called Gabapentin. The medication is in tablet form with 100 tablets in the package. The label indicates that it is for prescription use only. Additionally, the text mentions certain percentages that could be related to the composition or dosage of the medication.*
Figure 1 - image 01

The text provides information about a pain study including mean pain scores and specific dosages of medications used. The study compares the effects of a placebo versus Gabapentin at a dosage of 3600 mg/day. The study also mentions dose titration for one group and a fixed dose period for another. The data collected includes baseline information and data from different weeks of the study.*
Figure 2 - image 02

This text presents data related to a research study on the effect of different doses of Gabapentin on pain scores over a 5-week period. The study compares placebo to Gabapentin at doses of 1800 mg/day and 2400 mg/day. The results include the mean pain score over the weeks, with the baseline and subsequent scores shown for each week.*
Figure 3 - image 03

This text appears to show information related to a comparison of the proportion of responders (patients with a 50% or more reduction in pain score) in controlled studies related to Post-Herpetic Neuralgia (PHN). The data seems to include percentages and the dosages or treatments being compared, including a placebo and GBP (potentially Gabapentin). The information is detailed with references to different studies and their results at the endpoint.*
image-09 - image 09

This is a table displaying information about the daily dose (in mg) for different substances labeled as A, B, and C. The values shown are for 600, 1200, and 1600 mg. The substances are identified by their alphabetic designations.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.